期刊文献+

非瓣膜病心房颤动患者抗凝治疗现状与指南差距分析 被引量:6

Gap Analysis of the Present Situation and the Guideline for Anticoagulation Treatment in Patients with Non Valvular Atrial Fibrillation
下载PDF
导出
摘要 目的:了解心房颤动抗凝治疗的现状、影响因素及其与指南推荐的差距。方法:调查2011年1月-2011年6月在本院住院的109例非瓣膜病心房颤动患者的血栓栓塞危险因素、抗凝药物使用情况,采用logistic回归分析法分析影响抗凝治疗的相关因素。结果:具有抗凝指征且无抗凝禁忌证的患者102例,仅12.7%的患者接受华法林治疗,年龄≥75岁、患者对抗凝治疗的选择是影响抗凝治疗的主要因素。结论:本院抗凝治疗的现状与指南推荐差距明显。 Objective: To investigate the gap between the present situation and the guideline for anticoagu!ation therapy in patients with non valvular atrial fibrillation, and analyze the related factors which influence the decision of anticoagulation therapy.Method: Risk factors of thrombo- embolism and usage of anticoagulant were investigated in 109 hospitalized patients with non valvular atrial fibrillation during January 2011 to June 2012, and the related factors which influence the decision of anticoagulation therapy were analyzed using logistic regression analysis.Result: 102 patients had anticoagulation indications and no anticoagulation contraindication, only 12.7 percent of patients were treated with warfarin; age ~ 75 years and the choice of patients were the main factors influencing anticoagulant therapy.Conclusion: There is an obvious gap between the present situation and the guideline for anticoagulation therapy in patients with non valvular atrial fibrillation.
出处 《中国医学创新》 CAS 2013年第21期101-103,共3页 Medical Innovation of China
关键词 心房颤动 血栓栓塞 抗凝治疗 Atrial fibrillation Thrombo-embolism Anticoagulation therapy
  • 相关文献

参考文献9

  • 1Fuster V,Rydén L E,Cannom D S,et al.ACC/AHA/ESC2006Guidelines for the management of patients with atrial fibrillation[J].Circulation,2006,114(7):257-354.
  • 2黄从新,张澍,马长生,杨延宗,黄德嘉,曹克将,江洪,杨新春,吴书林,商丽华,张奎俊,李莉,丁燕生,马坚,王祖禄,刘少稳,刘旭,董建增,姚焰,陈柯萍,陈明龙,王方正,陈新.心房颤动:目前的认识和治疗建议-2010[J].中华心律失常学杂志,2010,14(5):328-369. 被引量:93
  • 3郭继鸿.心房颤动的新理念[J].临床心电学杂志,2010,19(5):381-392. 被引量:34
  • 4Laupacis A,Boysen G,Connolly S,et al.Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation:analysis of pooled data from five randomized controlled trials[J].Arch lntern Med,1994,154(13):1449-1457.
  • 5Hart R G,Pearce L A,Aguilar M I.Meta-analysis:antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med,2007,146(12):857-867.
  • 6Mant J,Hobbs F D R,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation(the Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomised controlled trial[J].Lancet,2007,370(9586):493-503.
  • 7马长生.心房颤动抗栓药物治疗进展[J].临床药物治疗杂志,2011,9(3):1-5. 被引量:11
  • 8张玉芝,余娟,邵珊,陈秉乾,张祖峰,周丽,尹红君.非瓣膜病心房颤动住院患者抗凝治疗现状及影响因素分析[J].临床心血管病杂志,2010,26(6):443-446. 被引量:13
  • 9张秀锦,李小鹰.老年心房颤动患者抗凝治疗影响因素分析[J].中华保健医学杂志,2009,11(3):183-185. 被引量:34

二级参考文献77

共引文献179

同被引文献63

  • 1赵洁,李超鹏,张之慧.心房颤动患者华法林抗凝治疗依从性调查分析[J].农垦医学,2014,36(1):68-71. 被引量:3
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3左惠娟,苏江莲,曾辉,袁宝弘,姚崇华.北京市非瓣膜心房颤动病人日常抗血栓治疗现况分析[J].中华医学杂志,2007,87(33):2328-2331. 被引量:18
  • 4Go A S,Hylek E M,Phillips K A,et al.Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the An Ticoagulation and Risk Factors in Atrial Fibrillation(ATRIA)Study[J].JAMA,2001,285(18):2370-2375.
  • 5Swedberg K,Olsson L G,Charlesworth A,et al.Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers:results from COMET[J].Eur Heart J,2005,26(13):1303-1308.
  • 6Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.Analysis of pooled data from five randomized controlled trials[J].Arch Intern Med,1994,154(13):1449-1457.
  • 7Stewart S,Hart C L,Hole D J,et al.A population-based study of the long-term risks associated with atrial fibrillation:20-year follow-up of the Renfrew/Paisley study[J].Am J Med,2002,113(5):359-364.
  • 8Benjamin E J,Wolf P A,D'Agostino R B,et al.Impact of atrial fibrillation on the risk of death:the Framingham Heart Study[J].Circulation,1998,98(10):946-952.
  • 9Lloyd-Jones D M, Wang T J, Leip E P, et al.Lifetime Risk for Devetopment of Atrial Fibrillation: The Framingham Heart Study[J]. Circulation, 2004, 25(110): 1042-1046.
  • 10Hart R G, Pearce L A, Aguilar M LMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation[J].Ann Intern Med, 2007, 146(12): g57-867.

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部